By taking advantage of the cytotoxicity effect of 5-FU and the pleiotropic drug effects of hinokitiol, i.e., P-gp downregulation, we suggest that hinokitiol can be utilized to reverse cancer drug resistance, particularly to 5-FU in the present model. Here, PGP is linked to cancer.